Advertisement
Screener

ImmuCell Corporation (ICCC) Derivative Asset, Noncurrent

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Derivative Asset, Noncurrent

ImmuCell Corporation (ICCC) had Derivative Asset, Noncurrent of $4.12 thousand as of 2019-03-31, per its 10-Q filed 2019-05-13.

Discontinued › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:DerivativeAssetsNoncurrent · last filed 2020-03-27

  • 2019-03-31: Derivative Asset, Noncurrent $4.12K.
  • 2018-12-31: Derivative Asset, Noncurrent $40.21K.
  • 2018-09-30: Derivative Asset, Noncurrent $98.39K.
  • 2018-06-30: Derivative Asset, Noncurrent $79.28K.
Period endDerivative Asset, Noncurrent
2019-03-31$4.12K
10-Q · filed 2019-05-13
2018-12-31$40.21K
10-K · filed 2020-03-27
2018-09-30$98.39K
10-Q · filed 2018-11-13
2018-06-30$79.28K
10-Q · filed 2018-08-13
2018-03-31$95.56K
10-Q · filed 2018-05-14
2017-12-31$95.56K
10-Q · filed 2018-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92